Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation.
Saved in:
| Title: | Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. |
|---|---|
| Authors: | Godfrey, Laura K.1,2 (AUTHOR), Forster, Jan2,3 (AUTHOR), Liffers, Sven-Thorsten1,2 (AUTHOR), Schröder, Christopher3 (AUTHOR), Köster, Johannes4 (AUTHOR), Henschel, Leonie5 (AUTHOR), Ludwig, Kerstin U.5 (AUTHOR), Lähnemann, David2 (AUTHOR), Trajkovic-Arsic, Marija1,2 (AUTHOR), Behrens, Diana6 (AUTHOR), Scarpa, Aldo7,8 (AUTHOR), Lawlor, Rita T.8 (AUTHOR), Witzke, Kathrin E.9 (AUTHOR), Sitek, Barbara9,10 (AUTHOR), Johnsen, Steven A.11,12 (AUTHOR), Rahmann, Sven13 (AUTHOR), Horsthemke, Bernhard14 (AUTHOR), Zeschnigk, Michael2,14 (AUTHOR), Siveke, Jens T.1,2,15 (AUTHOR) jens.siveke@uk-essen.de |
| Source: | Clinical Epigenetics. 1/16/2024, Vol. 16 Issue 1, p1-22. 22p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
